SCHEMBL943052

SCHEMBL943052

C#CCNC(=O)CBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5155451 0.77
SCHEMBL13844956 0.77
SCHEMBL256677 0.77
SCHEMBL29957485 0.75 KDM1A (0.39)
SCHEMBL2026442 0.75
SCHEMBL6256634 0.75
SCHEMBL9816683 0.75 KDM1A (0.36)
SCHEMBL4795813 0.75
SCHEMBL155344 0.75
SCHEMBL19248841 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122028913-A Oligonucleotides containing ligands in nucleobases, 2 'or 3' positions 阿达尔克斯制药有限公司 2026-05-12 CN disclosed
CN-116286817-B Nucleic acid aptamer for targeting p53-R175H, protein targeting degradation chimeric body and application thereof 山东师范大学 2025-05-02 CN disclosed
US-20250082768-A1 CONJUGATING REAGENTS AND CONJUGATES THEREOF CAMBRIDGE ENTERPRISE LIMITED (GB) 2025-03-13 US disclosed
CN-116179554-B Conditional protein targeted degradation chimeric based on nucleic acid aptamer, and preparation method and application thereof 山东师范大学 2025-03-04 CN disclosed
WO-2025038971-A1 OLIGONUCLEOTIDES CONTAINING A LIGAND AT A NUCLEOBASE, 2' POSITION, OR 3' POSITION ADARX PHARMACEUTICALS, INC. (US) 2025-02-20 WO disclosed
CN-117750982-A Coupling reagent and conjugate thereof 剑桥实业有限公司 2024-03-22 CN disclosed
US-20240083934-A1 N-ACETYLGALACTOSAMINE (GALNAC)-DERIVED COMPOUNDS AND OLIGONUCLEOTIDES ADARX PHARMACEUTICALS, INC. (US) 2024-03-14 US disclosed
EP-4225322-A1 N-ACETYLGALACTOSAMINE(GALNAC)-DERIVED COMPOUNDS AND OLIGONUCLEOTIDES Adarx Pharmaceuticals, Inc. (US) 2023-08-16 EP disclosed
CN-116546989-A N-acetylgalactosamine (GalNAc) derived compounds and oligonucleotides 阿达尔克斯制药有限公司 2023-08-04 CN disclosed
CN-116286817-A Nucleic acid aptamer for targeting p53-R175H, protein targeting degradation chimeric body and application thereof 山东师范大学 2023-06-23 CN disclosed
CN-101535334-A Method of covalently linking a carbohydrate or polyalkylene oxide to a peptide, precursors for use in the method and resultant products UCL BUSINESS PLC (GB) 2009-09-16 CN disclosed
US-20090227691-A1 METHOD FOR RELEASING MOLECULE OF INTEREST BASED ON TARGET NUCLEIC ACID SEQUENCE RIKEN (JP) 2009-09-10 US disclosed
US-20090196829-A1 MRI CONTRAST AGENTS AND RELATED METHODS OF USE NORTHWESTERN UNIVERSITY (US) 2009-08-06 US disclosed
EP-2046810-A2 METHOD OF COVALENTLY LINKING A CARBOHYDRATE OR POLYALKYLENE OXIDE TO A PEPTIDE, PRECURSORS FOR USE IN THE METHOD AND RESULTANT PRODUCTS. UCL Business PLC (GB) 2009-04-15 EP disclosed
US-20090010846-A1 Nitro-Imidazole Hypoxia Imaging Agents SIEMENS MEDICAL SOLUTIONS USA, INC. 2009-01-08 US disclosed
US-20090010846-A1 Nitro-Imidazole Hypoxia Imaging Agents SIEMENS MEDICAL SOLUTIONS USA, INC. 2009-01-08 US disclosed
WO-2008124651-A2 NITRO-IMIDAZOLE HYPOXIA IMAGING AGENTS SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2008-10-16 WO disclosed
WO-2008124651-A2 NITRO-IMIDAZOLE HYPOXIA IMAGING AGENTS SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2008-10-16 WO disclosed
WO-2008001109-A2 METHOD OF COVALENTLY LINKING A CARBOHYDRATE OR POLYALKYLENE OXIDE TO A PEPTIDE, PRECURSORS FOR USE IN THE METHOD AND RESULTANT PRODUCTS UCL BUSINESS PLC (GB) 2008-01-03 WO disclosed
WO-2008001109-A2 METHOD OF COVALENTLY LINKING A CARBOHYDRATE OR POLYALKYLENE OXIDE TO A PEPTIDE, PRECURSORS FOR USE IN THE METHOD AND RESULTANT PRODUCTS UCL BUSINESS PLC (GB) 2008-01-03 WO disclosed